These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6202804)

  • 1. Correlation between opsonic activity for various microorganisms and composition of gammaglobulin preparations for intravenous use.
    van Furth R; Leijh PC; Klein F
    J Infect Dis; 1984 Apr; 149(4):511-7. PubMed ID: 6202804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opsonic activity and composition of five intramuscular gammaglobulin preparations.
    van Furth R; Braat AG; Leijh PC; Klein F
    J Infect; 1986 Nov; 13(3):269-75. PubMed ID: 2432132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of antibody activity against various microorganisms in intravenous immunoglobulin preparations determined by ELISA and opsonic assay.
    Hiemstra PS; Brands-Tajouiti J; van Furth R
    J Lab Clin Med; 1994 Feb; 123(2):241-6. PubMed ID: 8301200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opsonic activity of a new intravenous immunoglobulin preparation: Pentaglobin compared with sandoglobulin.
    Garbett ND; Munro CS; Cole PJ
    Clin Exp Immunol; 1989 Apr; 76(1):8-12. PubMed ID: 2500275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A human IgG 3 is opsonic in vitro against type III group B streptococci.
    Kim JS; Kim KS; Wass CA; Short JA; Heiner DC
    J Clin Immunol; 1990 May; 10(3):154-9. PubMed ID: 2195055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opsonic activity of human IgG and IgM antibody for type III group B streptococci.
    Anthony BF; Concepcion NF
    Pediatr Res; 1989 Oct; 26(4):383-7. PubMed ID: 2677951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opsonic activity of immunoglobulin prepared for intravenous use.
    Hetherington SV; Giebink GS
    J Lab Clin Med; 1984 Dec; 104(6):977-86. PubMed ID: 6502004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of bacterial opsonization by immune globulin intravenous: correlation of complement consumption with opsonic activity and protective efficacy.
    Yang KD; Bathras JM; Shigeoka AO; James J; Pincus SH; Hill HR
    J Infect Dis; 1989 Apr; 159(4):701-7. PubMed ID: 2494269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirements for the opsonic activity of human IgG directed to type 6 group A streptococci: net basic charge and intact Fc region.
    Fischetti VA
    J Immunol; 1983 Feb; 130(2):896-902. PubMed ID: 6336773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative opsonic activity of intravenous gamma globulin preparations for common bacterial pathogens.
    Hill HR; Augustine NH; Shigeoka AO
    Am J Med; 1984 Mar; 76(3A):61-6. PubMed ID: 6424458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reactivity to bacterial peptidoglycans in a phagocytosis system. The range of immunological specificity of Escherichia coli peptidoglycan].
    Azov NA
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Jul; (7):74-7. PubMed ID: 2413663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opsonic activity of cord blood sera against various species of microorganism.
    Máródi L; Leijh PC; Braat A; Daha MR; van Furth R
    Pediatr Res; 1985 May; 19(5):433-6. PubMed ID: 3889816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified human immune serum globulin for intravenous administration: in vitro opsonic activity and in vivo protection against group B streptococcal disease in suckling rats.
    Fischer GW; Hunter KW; Wilson SR
    Acta Paediatr Scand; 1982 Jul; 71(4):639-44. PubMed ID: 6753478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the composition and opsonic activities of imported and South African-manufactured intravenous and intramuscular immunoglobulin preparations.
    Theron AJ; Jooné GK; Anderson R
    S Afr Med J; 1994 Nov; 84(11):743-6. PubMed ID: 7495010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulins as aspecific opsonins. II. The influence of specific and aspecific immunoglobulins on the in vitro phagocytosis of noncapsulated, capsulated, and decapsulated bacteria by human neutrophils.
    Stinson MW; Van Oss CJ
    J Reticuloendothel Soc; 1971 May; 9(5):503-12. PubMed ID: 4104066
    [No Abstract]   [Full Text] [Related]  

  • 16. Monoclonal opsonic mouse antibodies specific for streptococcal IgG Fc-receptor.
    Svensson M; Christensen P; Schalén D
    J Med Microbiol; 1986 Nov; 22(3):251-6. PubMed ID: 2945929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opsonic and physicochemical characteristics of intravenous immunoglobulin preparations.
    van Furth R; Braat AG; Leijh PC; Gardi A
    Vox Sang; 1987; 53(2):70-5. PubMed ID: 3500539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opsonic activity of commercially available standard intravenous immunoglobulin preparations.
    Weisman LE; Cruess DF; Fischer GW
    Pediatr Infect Dis J; 1994 Dec; 13(12):1122-5. PubMed ID: 7892082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibronectin enhances the opsonic and protective activity of monoclonal and polyclonal antibody against group B streptococci.
    Hill HR; Shigeoka AO; Augustine NH; Pritchard D; Lundblad JL; Schwartz RS
    J Exp Med; 1984 Jun; 159(6):1618-28. PubMed ID: 6374010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum heat-labile opsonins in systemic lupus erythematosus.
    Jasin HE; Orozco JH; Ziff M
    J Clin Invest; 1974 Feb; 53(2):343-53. PubMed ID: 11344546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.